1月13日 - ** 基因测序解决方案公司Illumina ILMN.O股价最高上涨3.7%至151美元
** 预计第四季度营收为11.6亿美元，高于分析师预期的11亿美元（(link)，根据LSEG汇编的数据）。
** 预计第四季度调整后每股收益为1.27美元至1.30美元，高于预期的1.21美元
** 该公司与阿斯利康AZN.L、默克MRK.N和礼来LLY.N等制药商合作，推出了映射基因变化的数据集 (link)，以帮助通过人工智能加速药物发现。
** ILMN 在过去12个月中上涨了6.5%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.